Marc Jouan

870 total citations
14 papers, 505 citations indexed

About

Marc Jouan is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Marc Jouan has authored 14 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Marc Jouan's work include HIV Research and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Marc Jouan is often cited by papers focused on HIV Research and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Marc Jouan collaborates with scholars based in France, Netherlands and Spain. Marc Jouan's co-authors include Christine Katlama, Brigitte Gicquel, Pablo Bifani, Kristin Kremer, Carlos Martı́n, Sofía Samper, Jean Rauzier, Mina Ebrahimi‐Rad, Dick van Soolingen and Barry N. Kreiswirth and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.

In The Last Decade

Marc Jouan

14 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Jouan France 8 366 351 141 136 35 14 505
Somsit Tansuphaswadikul Thailand 11 369 1.0× 334 1.0× 69 0.5× 86 0.6× 11 0.3× 18 451
Perrine Parize France 11 234 0.6× 247 0.7× 43 0.3× 75 0.6× 7 0.2× 36 436
M. C. Meyohas France 7 198 0.5× 318 0.9× 27 0.2× 53 0.4× 7 0.2× 13 398
M.-W. Ho Taiwan 3 237 0.6× 106 0.3× 40 0.3× 67 0.5× 19 0.5× 4 406
P J Flegg United Kingdom 13 168 0.5× 172 0.5× 100 0.7× 19 0.1× 11 0.3× 28 390
James A. Krick United States 7 176 0.5× 297 0.8× 34 0.2× 49 0.4× 14 0.4× 9 537
Karin Norlin Sweden 5 274 0.7× 375 1.1× 16 0.1× 50 0.4× 10 0.3× 5 593
Jen-Hsien Wang Taiwan 12 295 0.8× 160 0.5× 25 0.2× 166 1.2× 6 0.2× 20 513
Iker Falces‐Romero Spain 11 237 0.6× 188 0.5× 23 0.2× 23 0.2× 10 0.3× 60 377
Angie E. Bartok United States 5 217 0.6× 416 1.2× 47 0.3× 61 0.4× 3 0.1× 5 526

Countries citing papers authored by Marc Jouan

Since Specialization
Citations

This map shows the geographic impact of Marc Jouan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Jouan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Jouan more than expected).

Fields of papers citing papers by Marc Jouan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Jouan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Jouan. The network helps show where Marc Jouan may publish in the future.

Co-authorship network of co-authors of Marc Jouan

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Jouan. A scholar is included among the top collaborators of Marc Jouan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Jouan. Marc Jouan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Dupont‐Rouzeyrol, Myrielle, et al.. (2023). Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021. IJID Regions. 8. 64–70. 4 indexed citations
2.
Boucher, François, et al.. (2008). Does selenium exert cardioprotective effects against oxidative stress in myocardial ischemia?. Acta Physiologica Hungarica. 95(2). 187–194. 11 indexed citations
3.
Martinez, Valérie, Guislaine Carcelain, Edgar Badell, et al.. (2007). T-cell and serological responses to Erp, an exported Mycobacterium tuberculosisprotein, in tuberculosis patients and healthy individuals. BMC Infectious Diseases. 7(1). 83–83. 9 indexed citations
4.
Jouan, Marc, Vincent Jullien, Tetanye Ekoe, et al.. (2005). Quinine Pharmacokinetics and Pharmacodynamics in Children with Malaria Caused by Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. 49(9). 3658–3662. 15 indexed citations
5.
Ebrahimi‐Rad, Mina, Pablo Bifani, Carlos Martı́n, et al.. (2003). Mutations in Putative Mutator Genes ofMycobacterium tuberculosisStrains of the W-Beijing Family. Emerging infectious diseases. 9(7). 838–845. 220 indexed citations
6.
Zeller, Valérie, Rachid Agher, P Bossi, et al.. (2002). Discontinuation of Secondary Prophylaxis against Disseminated Mycobacterium avium Complex Infection and Toxoplasmic Encephalitis. Clinical Infectious Diseases. 34(5). 662–667. 29 indexed citations
7.
Jouan, Marc, Marianne Savès, Roland Tubiana, et al.. (2001). Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS. 15(1). 23–31. 71 indexed citations
8.
Baril, Laurence, Marc Jouan, Rachid Agher, et al.. (2000). Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS. AIDS. 14(16). 2593–2596. 30 indexed citations
9.
Klement-Frutos, Elise, et al.. (2000). [Coxiella burnetii pneumopathy on return from French Guiana].. PubMed. 93(5). 325–7. 6 indexed citations
10.
Mary‐Krause, Murielle, et al.. (2000). [Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. Clinical Epidemiology Group of the Information and Care Center for Human Immunodeficiency].. PubMed. 48(5). 495–504. 1 indexed citations
11.
Katlama, Christine, Alain Mallet, Vincent Cálvez, et al.. (1999). Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen. AIDS. 13(6). 669–676. 100 indexed citations
12.
Jouan, Marc & Christine Katlama. (1999). Management of CMV retinitis in the era of highly active antiretroviral therapy. International Journal of Antimicrobial Agents. 13(1). 1–7. 5 indexed citations
13.
Caumes, Éric, Herve Momméja-Marin, O. Chosidow, et al.. (1998). Facial Folliculitis Due toClostridium perfringensin a Patient Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 26(2). 501–501. 2 indexed citations
14.
Jouan, Marc. (1998). [Opportunistic infections in patients under highly concentrated antiretroviral therapy].. PubMed. 27 Suppl 5. 21–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026